Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Low-dose ethinyl estradiol and LNG-IUD are safer contraception options for obese women with PCOS.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Fetal ovaries produce different hormones than adult ovaries, and endocrine-disrupting chemicals may affect this process.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Menopause causes dry skin, wrinkles, and hair changes, with hormone therapy helping but not recommended just for these issues.

The method can measure multiple steroids in human hair to study long-term steroid metabolism, especially in newborns and children.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Some birth control pills have a higher risk of blood clots than others.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.